GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Cyclically Adjusted PB Ratio

Walvax Biotechnology Co (SZSE:300142) Cyclically Adjusted PB Ratio : 3.82 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Walvax Biotechnology Co's current share price is ¥13.60. Walvax Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥3.56. Walvax Biotechnology Co's Cyclically Adjusted PB Ratio for today is 3.82.

The historical rank and industry rank for Walvax Biotechnology Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300142' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.82   Med: 14.49   Max: 35.09
Current: 3.82

During the past years, Walvax Biotechnology Co's highest Cyclically Adjusted PB Ratio was 35.09. The lowest was 3.82. And the median was 14.49.

SZSE:300142's Cyclically Adjusted PB Ratio is ranked worse than
75.14% of 692 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs SZSE:300142: 3.82

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Walvax Biotechnology Co's adjusted book value per share data for the three months ended in Mar. 2024 was ¥5.825. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.56 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Walvax Biotechnology Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Walvax Biotechnology Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Cyclically Adjusted PB Ratio Chart

Walvax Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.57 15.63 20.32 12.86 6.80

Walvax Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.76 8.08 6.96 6.80 4.32

Competitive Comparison of Walvax Biotechnology Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walvax Biotechnology Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's Cyclically Adjusted PB Ratio falls into.



Walvax Biotechnology Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Walvax Biotechnology Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=13.60/3.56
=3.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Walvax Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Walvax Biotechnology Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.825/115.2271*115.2271
=5.825

Current CPI (Mar. 2024) = 115.2271.

Walvax Biotechnology Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.903 98.200 2.233
201409 1.840 98.900 2.144
201412 2.053 99.000 2.390
201503 2.019 99.900 2.329
201506 1.990 99.500 2.305
201509 2.051 100.500 2.352
201512 1.627 100.600 1.864
201603 1.597 102.200 1.801
201606 1.535 101.400 1.744
201609 1.355 102.400 1.525
201612 2.086 102.600 2.343
201703 2.062 103.200 2.302
201706 2.053 103.100 2.294
201709 2.055 104.100 2.275
201712 1.969 104.500 2.171
201803 2.184 105.300 2.390
201806 2.214 104.900 2.432
201809 2.396 106.600 2.590
201812 2.979 106.500 3.223
201903 3.012 107.700 3.223
201906 3.105 107.700 3.322
201909 3.138 109.800 3.293
201912 3.164 111.200 3.279
202003 3.144 112.300 3.226
202006 3.307 110.400 3.452
202009 3.742 111.700 3.860
202012 4.233 111.500 4.374
202103 4.514 112.662 4.617
202106 4.720 111.769 4.866
202109 5.095 112.215 5.232
202112 5.298 113.108 5.397
202203 5.383 114.335 5.425
202206 5.591 114.558 5.624
202209 5.544 115.339 5.539
202212 5.652 115.116 5.657
202303 5.760 115.116 5.766
202306 5.881 114.558 5.915
202309 5.942 115.339 5.936
202312 5.817 114.781 5.840
202403 5.825 115.227 5.825

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Walvax Biotechnology Co  (SZSE:300142) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Walvax Biotechnology Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Walvax Biotechnology Co (SZSE:300142) Business Description

Traded in Other Exchanges
N/A
Address
Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Executives
Wu Yun Yan Executives
Zhao Jin Long Executives
Yao Wei Executives
Zhou Hua Executives
Shi Jing Executives
Jiang Run Sheng Directors, executives
Gong Sun Qing Executives
Executives
Yuan Lin Executives
Fang Guo Liang Executives
Li Yun Chun Director
Huang Zhen Director
Zhang Li Secretary Dong
Yang Hong Wei Supervisors
Xu Ke Ren Executives

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines